|
Rheumatoid
Arthritis
What is
Rheumatoid Arthritis?
Rheumatoid arthritis (RA) is a
chronic disease that causes pain, stiffness, swelling and loss of function
in the joints and inflammation in other body organs.
return to top
Known Causes
While the cause of RA remains unknown, rapidly advancing research is
discovering the bodily reactions that lead to arthritis and joint damage.
Recent studies show that certain people inherit a tendency to develop RA.
Health Impact
-
RA affects more than two million Americans.
-
Direct and indirect costs of RA reached $65 billion in 1992.
-
More than 75 percent of RA patients are women.
-
Peak onset is between age 20 and 45.
-
Osteoporosis is common in patients with RA.
return to top
Diagnosis
RA can be difficult to diagnose early
because it may begin gradually with subtle symptoms. Blood tests and X-rays
may be normal initially. The disease varies among individuals with respect
to symptoms, joints affected and the nature of other organs involved, such
as the eyes, lungs or skin. Other types of arthritis may mimic RA. Skill and
experience are essential to reach a precise diagnosis and to arrive at the
most appropriate treatment.
The diagnostic criteria established by the American College of
Rheumatology include prolonged morning stiffness in the joints,
characteristic nodules under the skin, joint erosions apparent on X-ray
tests, and blood tests of an antibody known as rheumatoid factor.
return to top
Conventional
treatments
Therapy for patients with RA has improved dramatically over the last 25
years, offering most patients good to excellent relief of symptoms and the
ability to continue to function at or near normal levels. There is no cure
for RA; therefore, the goal of treatment is to minimize patients’
symptoms.
Successful management of RA requires early diagnosis and aggressive
treatment before functional impairment and irreversible joint damage has
occurred. Nonsteroidal anti-inflammatory drugs such as ibuprofen may be used
first, but all RA patients with persistent swelling in the joints are
candidates for treatment with disease-modifying drugs. These drugs include
methotrexate, hydroxychloroquine, sulfasalzine, corticosteroids,
intramuscular and oral gold, d-penicillamine, minocycline, azathioprine,
cyclosporine, leflunomide, and etanercept.
Optimal treatment requires comprehensive coordinated care, patient
education and the expertise of a number of providers, including
rheumatologists, primary care physicians, nurses, occupational and physical
therapists, physiatrists and orthopedic surgeons. With the tremendous
success of total joint replacement surgery (especially for the hip and knee)
many patients with advanced disease have continued to be active and mobile.
return to top
This page was last updated on 05 December 2006 16:53:10
|